In fact, an increasing number of studies have recently confirmed that IFN-γ acts as a disease-limiting factor in CIA and not a pathogenic factor [40, 41], though several studies have recently revealed a role for IFN-α in the pathogenesis of a subset of RA patients [42]. This evidence concerns the gene IFNG and rheumatoid arthritis.